Demand for infection prevention products and services to exceed US$27bn by 2020
Although falling, the overall rate of some HAIs is significantly above targeted levels set by the US Centers for Disease Control and Prevention
US demand for infection prevention products and services is expected to grow 4.9% annually to US$27.6bn in 2020, according to a new study from market research group Freedonia.
Increasing pressures on hospitals and other healthcare facilities to cut rates of healthcare-associated infections (HAIs) are expected to boost revenue generated by infection prevention supplies, equipment and services, the report, Infection Prevention Products & Services, forecasts.
Although declining, the overall rate of some HAIs in hospitals is significantly above targeted levels set by the US Centers for Disease Control and Prevention (CDC). Recent statistics indicate that only 25% of acute care facilities meet established guidelines related to the incidence of catheter-associated urinary tract and central-line-associated blood stream infections. These and other trends are presented in the study.
Demand for infection prevention supplies is projected to rise 4.7% annually to more than $21bn in 2020. Protective clothing and textiles will continue to account for the largest share of revenue as intensified efforts by hospitals and other medical providers to hold down the incidence of HAIs in patient care promote the increasing use of higher quality, barrier-enhanced products.
Waste disposal containers and accessories will post the fastest growth in demand among infection prevention supplies, spurred by the upgrading of infectious waste collection and processing sites in healthcare and life science facilities.
The market for sterilisation and related equipment will rise as the healthcare and life science sectors seek to keep up with advancing infection prevention technologies and capabilities. Total demand for this equipment is expected to reach $1.1bn in 2020, up 2.9% annually from 2015.
The maturing of hospital, outpatient and life science markets, coupled with the widening availability of used and retrofitted devices and systems, will moderate faster gains, suggests the report.
The market for infection prevention services is forecast to increase 6.1% annually to $5.5bn in 2020. Infectious waste disposal services will dominate demand as government restrictions on onsite incineration remain in place, prompting health facilities to use outside firms for infectious waste collection and disposal.
Although serving a more limited customer base, contract sterilisation services will see favourable revenue growth. An increasing number of pharmaceutical and medical device producers will rely on outside contractors to implement sterilisation processes to avoid the extensive capital investment required to set up and operate in-house systems.